Biana Godin Vilentchouk PhD, MSc, Pharm

Dr. Biana Godin Vilentchouk earned her Ph.D. in Pharmaceutical Sciences from the Hebrew University of Jerusalem in 2006. During her Ph.D. studies, Dr. Godin Vilentchouk focused on designing a non-invasive treatment for the hard-to-treat skin deep infections and on nasal delivery of proteins. She was recruited as a Postdoctoral trainee in the field of Cancer Nanotechnology to the research team of Dr. Mauro Ferrari at the University of Texas Health Sciences Center.

Her postdoctoral research focused on injectable multistage nanovectors (MSVs) for cancer treatment and imaging. Her work provided insightful understanding of the interactions of MSVs with immune cells in vivo and in vitro, biocompatibility of MSV, effect of geometry and targeting moieties on MSV biodistribution, and evaluation of MSV systems as near-infra red and MRI imaging agents. During the three years of her postdoctoral research, Dr. Godin Vilentchouk published numerous book chapters, and peer-reviewed articles and reviews in top journals including Nature Nanotechnology and Cancer Research.

She also received awards for her work at international conferences. In October 2010, Dr. Biana Godin Vilentchouk joined the Department of Nanomedicine at the Research Institute.